JavaScript is disabled for your browser. Some features of this site may not work without it.
Statistics
Total Visits
| Views | |
|---|---|
| Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial | 46 |
Total Visits Per Month
| March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
|---|---|---|---|---|---|---|---|
| Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial | 4 | 0 | 0 | 1 | 0 | 12 | 4 |
File Visits
| Views | |
|---|---|
| pal-fuo-targ.pdf | 38 |
Top country views
| Views | |
|---|---|
| United States | 33 |
| Belgium | 6 |
| Spain | 3 |
| China | 2 |
| Argentina | 1 |
| Australia | 1 |
Top cities views
| Views | |
|---|---|
| Boardman | 7 |
| Ann Arbor | 6 |
| San Ramon | 5 |
| Menlo Park | 4 |
| Ashburn | 2 |
| Fairfield | 2 |
| Madrid | 2 |
| Barcelona | 1 |
| Rochester | 1 |
| San Diego | 1 |
Search DSpace
Browse
My Account
Statistics
